| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retroviridae Infections | 23 | 2023 | 48 | 6.180 |
Why?
|
| Mammary Tumor Virus, Mouse | 41 | 2017 | 64 | 5.770 |
Why?
|
| Retroviridae | 5 | 2023 | 79 | 2.740 |
Why?
|
| Virus Diseases | 5 | 2019 | 99 | 2.150 |
Why?
|
| Histocompatibility Antigens Class II | 6 | 2024 | 166 | 2.000 |
Why?
|
| Antibodies, Neutralizing | 6 | 2020 | 123 | 1.890 |
Why?
|
| Viruses | 5 | 2019 | 78 | 1.870 |
Why?
|
| Tumor Virus Infections | 17 | 2011 | 83 | 1.860 |
Why?
|
| Mice | 58 | 2025 | 11869 | 1.750 |
Why?
|
| HLA-D Antigens | 3 | 2021 | 20 | 1.540 |
Why?
|
| Antibodies, Viral | 11 | 2018 | 311 | 1.470 |
Why?
|
| Mammary Neoplasms, Experimental | 11 | 2006 | 127 | 1.320 |
Why?
|
| Immunity, Innate | 11 | 2019 | 434 | 1.230 |
Why?
|
| Animals | 62 | 2025 | 27550 | 1.140 |
Why?
|
| Symbiosis | 4 | 2022 | 127 | 1.140 |
Why?
|
| Mice, Inbred Strains | 9 | 2023 | 308 | 1.100 |
Why?
|
| Leukemia Virus, Murine | 5 | 2023 | 18 | 1.030 |
Why?
|
| Mice, Transgenic | 13 | 2025 | 1580 | 1.010 |
Why?
|
| Immunity, Humoral | 2 | 2017 | 66 | 0.990 |
Why?
|
| Immunoglobulins | 2 | 2024 | 143 | 0.930 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2024 | 395 | 0.920 |
Why?
|
| V(D)J Recombination | 1 | 2024 | 11 | 0.910 |
Why?
|
| Metagenome | 3 | 2013 | 105 | 0.840 |
Why?
|
| Superantigens | 9 | 2004 | 24 | 0.840 |
Why?
|
| Bacterial Physiological Phenomena | 2 | 2013 | 42 | 0.810 |
Why?
|
| Polymorphism, Genetic | 3 | 2021 | 826 | 0.810 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2025 | 415 | 0.790 |
Why?
|
| Staphylococcus aureus | 2 | 2024 | 278 | 0.770 |
Why?
|
| Adaptive Immunity | 4 | 2019 | 167 | 0.760 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 272 | 0.750 |
Why?
|
| Intestines | 3 | 2019 | 416 | 0.720 |
Why?
|
| Leukemia | 1 | 2022 | 319 | 0.700 |
Why?
|
| Autoimmunity | 1 | 2021 | 172 | 0.690 |
Why?
|
| Bacteria | 5 | 2023 | 486 | 0.690 |
Why?
|
| Virus Physiological Phenomena | 1 | 2019 | 8 | 0.680 |
Why?
|
| Antigens, Viral | 9 | 2011 | 145 | 0.660 |
Why?
|
| Mice, Knockout | 9 | 2024 | 2017 | 0.650 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 2395 | 0.640 |
Why?
|
| Rauscher Virus | 2 | 2017 | 8 | 0.640 |
Why?
|
| Immunoglobulin G | 3 | 2018 | 469 | 0.630 |
Why?
|
| Immune Tolerance | 2 | 2020 | 344 | 0.620 |
Why?
|
| Mice, Inbred C3H | 17 | 2011 | 371 | 0.620 |
Why?
|
| Microbiota | 4 | 2025 | 410 | 0.580 |
Why?
|
| Mice, Inbred C57BL | 16 | 2024 | 3256 | 0.580 |
Why?
|
| Antigen Presentation | 5 | 2021 | 215 | 0.560 |
Why?
|
| T-Lymphocytes | 11 | 2006 | 1221 | 0.540 |
Why?
|
| Mice, Inbred BALB C | 11 | 2020 | 1091 | 0.510 |
Why?
|
| Caliciviridae Infections | 1 | 2015 | 10 | 0.490 |
Why?
|
| Norovirus | 1 | 2015 | 13 | 0.480 |
Why?
|
| Gastroenteritis | 1 | 2015 | 26 | 0.480 |
Why?
|
| Genes, gag | 3 | 2006 | 7 | 0.450 |
Why?
|
| Mammary Glands, Animal | 9 | 2006 | 80 | 0.450 |
Why?
|
| Germ-Free Life | 3 | 2025 | 77 | 0.450 |
Why?
|
| Chromosome Mapping | 6 | 2020 | 1074 | 0.440 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 601 | 0.440 |
Why?
|
| Interferon-gamma | 4 | 2018 | 449 | 0.420 |
Why?
|
| Immune Evasion | 2 | 2015 | 35 | 0.410 |
Why?
|
| Cytokines | 2 | 2015 | 812 | 0.400 |
Why?
|
| Viral Envelope Proteins | 6 | 2015 | 94 | 0.400 |
Why?
|
| Disease Susceptibility | 4 | 2023 | 200 | 0.390 |
Why?
|
| Carcinogenesis | 2 | 2025 | 216 | 0.390 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2011 | 8 | 0.380 |
Why?
|
| Mice, Congenic | 2 | 2021 | 12 | 0.370 |
Why?
|
| Virus Internalization | 1 | 2011 | 40 | 0.370 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 49 | 0.370 |
Why?
|
| Host-Pathogen Interactions | 4 | 2015 | 237 | 0.370 |
Why?
|
| Membrane Glycoproteins | 2 | 2011 | 432 | 0.360 |
Why?
|
| DNA, Viral | 8 | 2006 | 263 | 0.350 |
Why?
|
| Neoplasms | 1 | 2025 | 3011 | 0.340 |
Why?
|
| Virus Latency | 1 | 2009 | 33 | 0.330 |
Why?
|
| Peptides | 3 | 2021 | 650 | 0.330 |
Why?
|
| Female | 33 | 2025 | 46640 | 0.330 |
Why?
|
| Spleen | 3 | 2023 | 433 | 0.320 |
Why?
|
| B-Lymphocytes | 6 | 2014 | 740 | 0.310 |
Why?
|
| Hepatitis B | 2 | 2020 | 76 | 0.310 |
Why?
|
| Intestinal Mucosa | 2 | 2019 | 806 | 0.300 |
Why?
|
| Milk | 4 | 2004 | 53 | 0.280 |
Why?
|
| Endogenous Retroviruses | 2 | 2006 | 10 | 0.280 |
Why?
|
| Mammals | 2 | 2024 | 237 | 0.270 |
Why?
|
| Chronic Disease | 1 | 2009 | 956 | 0.260 |
Why?
|
| Molecular Sequence Data | 13 | 2006 | 3024 | 0.260 |
Why?
|
| Virion | 2 | 2005 | 59 | 0.260 |
Why?
|
| Virus Replication | 4 | 2013 | 326 | 0.260 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 6 | 1997 | 135 | 0.260 |
Why?
|
| Recombination, Genetic | 3 | 1997 | 446 | 0.250 |
Why?
|
| Wnt1 Protein | 1 | 2025 | 27 | 0.250 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2005 | 450 | 0.240 |
Why?
|
| Antigens, Viral, Tumor | 3 | 1998 | 15 | 0.230 |
Why?
|
| Base Sequence | 11 | 2004 | 2329 | 0.230 |
Why?
|
| Humans | 17 | 2024 | 90046 | 0.230 |
Why?
|
| Animals, Newborn | 4 | 2011 | 525 | 0.220 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 450 | 0.220 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 77 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 2360 | 0.210 |
Why?
|
| Amino Acid Sequence | 7 | 2006 | 2064 | 0.210 |
Why?
|
| Proviruses | 7 | 2006 | 15 | 0.210 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2014 | 78 | 0.210 |
Why?
|
| Metabolomics | 1 | 2023 | 76 | 0.200 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2025 | 522 | 0.200 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2023 | 319 | 0.200 |
Why?
|
| Hematopoiesis | 1 | 2002 | 168 | 0.190 |
Why?
|
| Blotting, Western | 4 | 2014 | 794 | 0.190 |
Why?
|
| Interleukin-10 | 4 | 2015 | 155 | 0.180 |
Why?
|
| Digestive System | 1 | 2020 | 42 | 0.180 |
Why?
|
| Mice, Inbred CBA | 5 | 2020 | 52 | 0.170 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2015 | 91 | 0.170 |
Why?
|
| HeLa Cells | 2 | 2020 | 515 | 0.170 |
Why?
|
| Peyer's Patches | 1 | 1999 | 18 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 374 | 0.170 |
Why?
|
| Immunity, Mucosal | 1 | 1999 | 70 | 0.160 |
Why?
|
| Antigen-Presenting Cells | 2 | 2001 | 142 | 0.150 |
Why?
|
| Male | 15 | 2020 | 42716 | 0.150 |
Why?
|
| Receptors, Virus | 1 | 1998 | 75 | 0.150 |
Why?
|
| RNA, Viral | 3 | 2004 | 318 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 314 | 0.140 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 1991 | 173 | 0.140 |
Why?
|
| Computational Biology | 2 | 2017 | 551 | 0.130 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2006 | 93 | 0.130 |
Why?
|
| Genetic Engineering | 2 | 2006 | 115 | 0.130 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2015 | 23 | 0.130 |
Why?
|
| Epithelium | 2 | 2014 | 323 | 0.130 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 1996 | 57 | 0.130 |
Why?
|
| Neutralization Tests | 2 | 2007 | 80 | 0.130 |
Why?
|
| Hepatitis C | 1 | 2017 | 174 | 0.120 |
Why?
|
| Selection, Genetic | 2 | 2003 | 517 | 0.120 |
Why?
|
| Models, Genetic | 2 | 2006 | 949 | 0.120 |
Why?
|
| Antigens, Neoplasm | 2 | 1989 | 334 | 0.120 |
Why?
|
| Species Specificity | 2 | 2014 | 685 | 0.120 |
Why?
|
| Fucose | 1 | 2014 | 13 | 0.120 |
Why?
|
| Cloning, Molecular | 5 | 2006 | 645 | 0.120 |
Why?
|
| Crosses, Genetic | 2 | 2006 | 171 | 0.120 |
Why?
|
| Freund's Adjuvant | 1 | 2014 | 26 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 295 | 0.110 |
Why?
|
| Ovalbumin | 1 | 2014 | 109 | 0.110 |
Why?
|
| Disease | 1 | 2014 | 90 | 0.110 |
Why?
|
| Gene Products, gag | 2 | 2012 | 12 | 0.110 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2014 | 135 | 0.110 |
Why?
|
| Cell Nucleolus | 1 | 2012 | 25 | 0.100 |
Why?
|
| Inflammation | 2 | 2020 | 982 | 0.100 |
Why?
|
| Virus Assembly | 1 | 2012 | 21 | 0.100 |
Why?
|
| Ribosomal Proteins | 1 | 2012 | 45 | 0.100 |
Why?
|
| Intestine, Small | 1 | 2014 | 299 | 0.100 |
Why?
|
| Poliovirus | 1 | 2012 | 23 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2011 | 2887 | 0.100 |
Why?
|
| Viral Core Proteins | 2 | 1989 | 28 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2417 | 0.100 |
Why?
|
| Melanoma, Experimental | 2 | 2003 | 111 | 0.100 |
Why?
|
| Milk, Human | 2 | 1989 | 46 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 1998 | 1227 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 1997 | 100 | 0.090 |
Why?
|
| HIV-1 | 1 | 2012 | 165 | 0.090 |
Why?
|
| Mice, Inbred DBA | 2 | 2004 | 150 | 0.090 |
Why?
|
| Genes, env | 3 | 2002 | 8 | 0.090 |
Why?
|
| Endosomes | 1 | 2011 | 79 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2011 | 120 | 0.090 |
Why?
|
| Pregnancy | 2 | 2011 | 3057 | 0.090 |
Why?
|
| Interferon Type I | 1 | 2011 | 186 | 0.090 |
Why?
|
| Cell Line | 6 | 2012 | 2494 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 602 | 0.080 |
Why?
|
| Pedigree | 3 | 1998 | 969 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2015 | 3406 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2005 | 691 | 0.080 |
Why?
|
| Toll-Like Receptors | 2 | 2014 | 93 | 0.080 |
Why?
|
| Kidney | 1 | 2014 | 1148 | 0.080 |
Why?
|
| Virus Integration | 2 | 2006 | 17 | 0.070 |
Why?
|
| Birds | 1 | 1990 | 166 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2006 | 1284 | 0.070 |
Why?
|
| Transcription, Genetic | 4 | 1999 | 1159 | 0.070 |
Why?
|
| Interferons | 1 | 2007 | 127 | 0.070 |
Why?
|
| Interleukin-12 | 1 | 2007 | 111 | 0.070 |
Why?
|
| Mice, Inbred AKR | 2 | 1997 | 10 | 0.070 |
Why?
|
| Oncogenes | 1 | 1987 | 97 | 0.070 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 3008 | 0.070 |
Why?
|
| Lymphoid Tissue | 1 | 2006 | 56 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 803 | 0.060 |
Why?
|
| Chromosomes | 1 | 2006 | 98 | 0.060 |
Why?
|
| Mutation | 1 | 2017 | 4169 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2006 | 202 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 136 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2006 | 211 | 0.060 |
Why?
|
| Adoptive Transfer | 1 | 2005 | 169 | 0.060 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2005 | 85 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 262 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 1998 | 1048 | 0.060 |
Why?
|
| Milk Proteins | 2 | 1999 | 24 | 0.060 |
Why?
|
| Haplotypes | 1 | 2006 | 638 | 0.060 |
Why?
|
| Interleukins | 2 | 2014 | 132 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 1008 | 0.060 |
Why?
|
| Terminal Repeat Sequences | 2 | 2004 | 9 | 0.050 |
Why?
|
| Lactation | 2 | 1994 | 54 | 0.050 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2003 | 43 | 0.050 |
Why?
|
| Viral Proteins | 1 | 1985 | 302 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2003 | 109 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2002 | 97 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2004 | 153 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2003 | 166 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 2 | 2003 | 354 | 0.050 |
Why?
|
| Isoantigens | 1 | 2002 | 71 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 418 | 0.050 |
Why?
|
| Gene Expression | 2 | 2019 | 1310 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 288 | 0.050 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2001 | 20 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2003 | 1380 | 0.050 |
Why?
|
| Enterotoxins | 1 | 2001 | 22 | 0.050 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2020 | 19 | 0.040 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2000 | 18 | 0.040 |
Why?
|
| Protein Binding | 2 | 2015 | 1492 | 0.040 |
Why?
|
| Virus Shedding | 1 | 2000 | 28 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2000 | 86 | 0.040 |
Why?
|
| Superinfection | 1 | 1999 | 3 | 0.040 |
Why?
|
| Defensins | 1 | 2019 | 5 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 83 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 198 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1999 | 141 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 354 | 0.040 |
Why?
|
| Cell Count | 1 | 1999 | 199 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2019 | 84 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 164 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 1 | 1999 | 111 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 161 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 141 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1990 | 243 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 251 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 2588 | 0.040 |
Why?
|
| Gene Amplification | 1 | 1998 | 135 | 0.040 |
Why?
|
| COS Cells | 1 | 1998 | 167 | 0.040 |
Why?
|
| Homeostasis | 1 | 2020 | 420 | 0.040 |
Why?
|
| Phenotype | 1 | 2004 | 2460 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1998 | 391 | 0.040 |
Why?
|
| Gammaretrovirus | 1 | 1997 | 4 | 0.040 |
Why?
|
| Alleles | 1 | 2020 | 1138 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 1999 | 754 | 0.030 |
Why?
|
| Nucleotides | 1 | 1997 | 99 | 0.030 |
Why?
|
| Reassortant Viruses | 1 | 1996 | 23 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 919 | 0.030 |
Why?
|
| Trans-Activators | 1 | 1999 | 443 | 0.030 |
Why?
|
| Cricetinae | 3 | 1991 | 558 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 1996 | 266 | 0.030 |
Why?
|
| Gene Library | 1 | 1995 | 132 | 0.030 |
Why?
|
| Citrobacter rodentium | 1 | 2014 | 14 | 0.030 |
Why?
|
| Protective Factors | 1 | 2014 | 23 | 0.030 |
Why?
|
| Fucosyltransferases | 1 | 2014 | 9 | 0.030 |
Why?
|
| Anorexia | 1 | 2014 | 28 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 128 | 0.030 |
Why?
|
| DNA Primers | 1 | 1995 | 543 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 44 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 86 | 0.030 |
Why?
|
| Clone Cells | 2 | 2003 | 214 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2014 | 134 | 0.030 |
Why?
|
| Virulence Factors | 1 | 2014 | 112 | 0.030 |
Why?
|
| Eating | 1 | 2014 | 167 | 0.030 |
Why?
|
| Lupus Nephritis | 1 | 2014 | 77 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 447 | 0.030 |
Why?
|
| DNA Probes | 2 | 1990 | 77 | 0.030 |
Why?
|
| Cell Communication | 1 | 2014 | 200 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2012 | 56 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 217 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 2012 | 43 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 1999 | 1244 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 139 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 86 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 81 | 0.030 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2012 | 96 | 0.030 |
Why?
|
| Biological Evolution | 2 | 1990 | 974 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 1992 | 100 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 423 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2014 | 451 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 981 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1992 | 284 | 0.020 |
Why?
|
| Acute Disease | 2 | 2003 | 850 | 0.020 |
Why?
|
| Plasmids | 2 | 1991 | 291 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1990 | 127 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1989 | 117 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 1989 | 84 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 693 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 97 | 0.020 |
Why?
|
| Breast | 1 | 1989 | 289 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 1987 | 41 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1992 | 2026 | 0.020 |
Why?
|
| Progesterone | 1 | 1985 | 110 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1985 | 303 | 0.010 |
Why?
|
| Azacitidine | 1 | 1985 | 148 | 0.010 |
Why?
|
| Estradiol | 1 | 1985 | 250 | 0.010 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2003 | 14 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2003 | 47 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 121 | 0.010 |
Why?
|
| Laminin | 1 | 2003 | 89 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2003 | 103 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2003 | 203 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2003 | 123 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 2003 | 93 | 0.010 |
Why?
|
| Toxoplasmosis | 1 | 2003 | 66 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1985 | 344 | 0.010 |
Why?
|
| Toxoplasma | 1 | 2003 | 116 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 294 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 885 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 405 | 0.010 |
Why?
|
| DNA | 1 | 1987 | 1312 | 0.010 |
Why?
|
| Necrosis | 1 | 2001 | 210 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2001 | 215 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2001 | 259 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2001 | 397 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 869 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 691 | 0.010 |
Why?
|
| Incidence | 1 | 2004 | 1589 | 0.010 |
Why?
|
| Transgenes | 1 | 1999 | 185 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 1999 | 43 | 0.010 |
Why?
|
| Prolactin | 1 | 1999 | 89 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2001 | 435 | 0.010 |
Why?
|
| Transfection | 1 | 1999 | 909 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1997 | 20 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 1766 | 0.010 |
Why?
|
| Clonal Deletion | 1 | 1995 | 23 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1995 | 97 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 1995 | 86 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1995 | 197 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 5353 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1995 | 465 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 29 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1992 | 278 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 154 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 4048 | 0.010 |
Why?
|
| Aging | 1 | 1995 | 727 | 0.010 |
Why?
|
| Genomic Library | 1 | 1990 | 33 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1990 | 67 | 0.010 |
Why?
|
| Genes, pol | 1 | 1989 | 3 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1995 | 1534 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1989 | 346 | 0.000 |
Why?
|
| Retroviridae Proteins | 1 | 1987 | 5 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1987 | 26 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1987 | 331 | 0.000 |
Why?
|
| Antibodies | 1 | 1987 | 353 | 0.000 |
Why?
|